Mariner’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,980
Closed -$265K 3556
2026
Q1
$265K Buy
+2,980
New +$306K ﹤0.01% 2983
2025
Q4
Sell
-2,150
Closed -$212K 3564
2025
Q3
$212K Sell
2,150
-1,193
-36% -$128K ﹤0.01% 3124
2025
Q2
$356K Buy
3,343
+592
+22% +$59.8K ﹤0.01% 2589
2025
Q1
$251K Sell
2,751
-475
-15% -$53.2K ﹤0.01% 2799
2024
Q4
$368K Sell
3,226
-1,944
-38% -$222K ﹤0.01% 2438
2024
Q3
$614K Sell
5,170
-8,431
-62% -$775K ﹤0.01% 1969
2024
Q2
$1.09M Sell
13,601
-320
-2% -$29.3K ﹤0.01% 1444
2024
Q1
$1.28M Sell
13,921
-301
-2% -$28.9K ﹤0.01% 1344
2023
Q4
$1.5M Buy
14,222
+11,553
+433% +$1.16M ﹤0.01% 1191
2023
Q3
$290K Buy
+2,669
New +$295K ﹤0.01% 2182

Other funds holding BNTX

Mariner's BNTX Position: Q2 2026 in Review

Mariner sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 2,980 shares — an estimated $265K sold.

Mariner first reported a position in BNTX in Q3 2023 and held it in 10 quarters. The position peaked at $1.5M in Q4 2023. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Mariner reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 2,980 BioNTech shares in Q2 2026, an estimated $265K.
  • Mariner first reported a position in BioNTech in Q3 2023 and held it in 10 quarters.
  • Mariner's BioNTech position peaked at $1.5M in Q4 2023.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.